2015
DOI: 10.4468/2015.2.05riboldazzi
|View full text |Cite
|
Sign up to set email alerts
|

R&D and Product Engineering in Global Pharmaceutical Companies

Abstract: Innovation and imitation processes play a major role in business development strategies of global pharmaceutical companies. In this study, we have analyzed some of the largest originator and generic pharmaceutical companies worldwide to determine which key features characterize such companies with a particular emphasis on new drug R&D processes.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2016
2016
2017
2017

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 33 publications
0
2
0
Order By: Relevance
“…ethical drugs, OTC, generics, etc.) and geographical area where they are produced (Riboldazzi, 2015b), they enter the distribution phase of the pharmaceutical supply chain.…”
Section: The Distribution Phase In the Pharmaceutical Supply Chain Inmentioning
confidence: 99%
“…ethical drugs, OTC, generics, etc.) and geographical area where they are produced (Riboldazzi, 2015b), they enter the distribution phase of the pharmaceutical supply chain.…”
Section: The Distribution Phase In the Pharmaceutical Supply Chain Inmentioning
confidence: 99%
“…Today, global firms are aware of the benefits of forming strategic alliances for location investments, destination marketing and product development. With networks and alliances, the management of tourism corporations will achieve greater economies of scale, marketing intelligence, quality control and cooperation (outside-in capabilities) (Brondoni, 2015;Riboldazzi, 2015).…”
Section: Tourism and Globalisationmentioning
confidence: 99%